EUVIMEDEUVIMED entdecken
Crossref

Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France

Tuba Tunçel

Review of Economic Studies · 09.05.2025 · 92 (3) · 2027-2070

DOI: 10.1093/restud/rdae060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Review of Economic Studies, online erschienen am 30.05.2024. Verfasst von Tuba Tunçel. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After a drug obtains marketing authorisation, the usage depends on the regulation of off-label prescriptions for unapproved indications. We investigate the impact of off-label prescription regulation on physicians’ behaviour, patients’ health, treatment costs, and pharmaceutical firms’ pricing with a structural demand and supply model. Exploiting rich panel data on physicians’ activities and office visits in France over 9 years, we use a model of prescription choice and health outcomes with unobserved patient-level heterogeneity. We identify the demand for on-label and off-label drugs and the effect of prescription choice on health outcomes. On the supply side, we use a Nash-in-Nash bargaining model between the government and the pharmaceutical companies that allows the partial identification of the marginal costs of drugs. Counterfactual simulations show that when we remove off-label drugs from the choice set of physicians, substitution to on-label drugs at constant prices would lead to an increase of 15% in the expenditure on prescription drugs. If we allow bargaining adjustment on drug prices under a ban on off-label prescriptions, the ban would further increase the treatment cost, by 26%, without improving health outcomes.

Zitieren

APA

Tunçel, T. (2025). Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France. Review of Economic Studies, 92(3), 2027-2070. https://doi.org/10.1093/restud/rdae060

Vancouver

Tunçel T. Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France. Review of Economic Studies. 2025;92(3):2027-2070. doi:10.1093/restud/rdae060

BibTeX
@article{Tunel2025,
  author = {Tunçel, Tuba},
  title = {Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France},
  journal = {Review of Economic Studies},
  year = {2025},
  volume = {92},
  number = {3},
  pages = {2027--2070},
  doi = {10.1093/restud/rdae060}
}
Kostenlos starten →